Lysolecithin is a selective reversible inhibitor of mitochondrial monoamine oxidase
- 1 January 1978
- journal article
- research article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 27 (8) , 1287-1288
- https://doi.org/10.1016/0006-2952(78)90466-5
Abstract
No abstract availableThis publication has 15 references indexed in Scilit:
- The effect of tris buffers on rat liver mitochondrial monoamine oxidaseJournal of Pharmacy and Pharmacology, 1977
- A model for the selective mode of action of the irreversible monoamine oxidase inhibitors clorgyline and deprenyl, based on studies of their ability to activate a Ca2+-Mg2+ ATPase in defined lipid environmentsJournal of Pharmacy and Pharmacology, 1977
- Purification and immunochemical characterization of monoamine oxidase from rat and human liverBiochemical Journal, 1977
- Multiple forms of monoamine oxidase: Fact and artefactLife Sciences, 1976
- Monoamine oxidase—IBiochemical Pharmacology, 1974
- Studies on the nature of the increased monoamine oxidase activity in the rat heart after adrenalectomyJournal of Pharmacy and Pharmacology, 1973
- The nature of the electrophoretically separable multiple forms of rat liver monoamine oxidaseBiochemical Journal, 1973
- Synthesis of lecithins by acylation of O-(sn-glycero-3-phosphoryl) choline with fatty acid anhydridesBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1969
- Human Liver Mitochondrial Monoamine OxidasePublished by Elsevier ,1968
- Some observations upon a new inhibitor of monoamine oxidase in brain tissueBiochemical Pharmacology, 1968